We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01789736
Recruitment Status : Completed
First Posted : February 12, 2013
Last Update Posted : March 17, 2014
Information provided by (Responsible Party):
Aerie Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2013
  Study Completion Date : June 2013
  Certification or Request for Extension to Delay Results Submission: February 17, 2014